03/26/2025
8:30 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/30/2024
7:07 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2024
6:32 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
6:00 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
9:01 AM | Biora Therapeutics (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
10/29/2024
3:43 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
7:37 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
10/29/2024
7:28 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
7:15 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
7:19 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
7:21 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for BIOR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/29/2024
7:24 AM | Biora Therapeutics (Filer)
| Form 424B3 | |
10/23/2024
4:24 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
10/11/2024
3:52 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
10/11/2024
7:00 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
4:40 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/16/2024
3:30 PM | Biora Therapeutics (Filer)
| Form DEF 14A | |
09/13/2024
9:37 AM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
09/05/2024
5:02 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
09/03/2024
3:31 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
08/23/2024
4:06 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024
4:08 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024
4:11 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/23/2024
4:13 PM | Biora Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/23/2024
4:03 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
08/21/2024
4:00 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
3:15 PM | Biora Therapeutics (Subject)
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP (Filed by)
| Form SC 13G | |
08/14/2024
8:57 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
8:58 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
08/12/2024
3:30 PM | Biora Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
3:15 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
7:05 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
8:42 PM | Athyrium Opportunities III Co-Invest 1 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
07/08/2024
8:15 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2024
8:00 PM | Athyrium Funds GP Holdings LLC (Reporting)
Athyrium Opportunities 2020 LP (Reporting)
Athyrium Opportunities Associates Co-Invest LLC (Reporting)
Athyrium Opportunities Associates III GP LLC (Reporting)
Athyrium Opportunities Associates III LP (Reporting)
Athyrium Opportunities III Acquisition 2 LP (Reporting)
Athyrium Opportunities III Acquisition LP (Reporting)
Athyrium Opportunities III Co-Invest 1 LP (Reporting)
Biora Therapeutics (Issuer)
Ferrell Jeffrey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
7:21 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
5:04 AM | Biora Therapeutics (Filer)
| Form 424B5 | |
07/01/2024
5:07 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:30 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
6:31 AM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Warning: “DOGE Collapse” imminent (Ad) Elon Strikes Back
You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead. Click here to see what they’re predicting now. |
06/06/2024
3:33 PM | Biora Therapeutics (Issuer)
Howe Jill Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:33 PM | Biora Therapeutics (Issuer)
Powell Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:33 PM | Alter Jeffrey D. (Reporting)
Biora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:33 PM | Biora Therapeutics (Issuer)
Kotzin Brian L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2024
11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
06/02/2024
11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/24/2024
3:06 PM | Biora Therapeutics (Filer)
| Form DEFA14A | |
04/24/2024
3:11 PM | Biora Therapeutics (Filer)
| Form ARS | |
04/17/2024
11:15 PM | Biora Therapeutics (Filer)
| Form EFFECT | |
04/12/2024
3:30 PM | Biora Therapeutics (Filer)
| Form PRE 14A | |
04/02/2024
7:43 PM | Athyrium Opportunities 2020 LP (Filed by)
Biora Therapeutics (Subject)
| Form SC 13D/A | |
04/02/2024
3:44 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024
3:46 PM | Biora Therapeutics (Filer)
| Form 424B5 | |
04/02/2024
3:48 PM | Biora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:45 PM | Biora Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
